Merger costs, forex weigh on Pfizer earnings
July 22, 2009 at 08:25 AM EDT
Pfizer reports lower second-quarter earnings, due largely to costs associated with its impending takeover of rival Wyeth.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.